+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Protein Therapeutics Market 2020-2024

  • PDF Icon

    Report

  • 120 Pages
  • April 2020
  • Region: Global
  • TechNavio
  • ID: 5027206
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Protein Therapeutics Market 2020-2024

The protein therapeutics market is poised to grow by $ 82.47 bn during 2020-2024 progressing at a CAGR of 7% during the forecast period. The reports on protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased demand for mAbs and the availability of favorable reimbursement policies.

The protein therapeutics market analysis includes product segment and geographic landscape.

The protein therapeutics market is segmented as below:

By Product
  • mAbs
  • Human insulin
  • Erythropoeitin
  • Clotting factors
  • Others

By Geographic Landscapes
  • North America
  • Europe
  • APAC
  • South America
  • MEA

This study identifies the development of novel therapies using innovative technologies as one of the prime reasons driving the protein therapeutics market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The protein therapeutics market covers the following areas:
  • Protein therapeutics market sizing
  • Protein therapeutics market forecast
  • Protein therapeutics market industry analysis.

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading protein therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novo Nordisk AS, Pfizer Inc., and Sanofi. Also, the protein therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • mAbs - Market size and forecast 2019-2024
  • Human insulin - Market size and forecast 2019-2024
  • Erythropoeitin - Market size and forecast 2019-2024
  • Clotting factors - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product

Market segmentation by Therapy Area
  • Market segments
  • Metabolic and endocrine disorders
  • Hematopoiesis
  • Fertility
  • Cancer
  • Autoimmune diseases
  • Infectious diseases
  • Protein vaccine

Market segmentation by Protein Function
  • Market segments
  • Enzymatic and regulatory activity
  • Special targeting activity
  • Vaccines
  • Protein diagnostics

Customer Landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ billion)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Product - Market share 2019-2024 (%)
22: Comparison by Product
23: mAbs - Market size and forecast 2019-2024 ($ billion)
24: mAbs - Year-over-year growth 2019-2024 (%)
25: Human insulin - Market size and forecast 2019-2024 ($ billion)
26: Human insulin - Year-over-year growth 2019-2024 (%)
27: Erythropoeitin - Market size and forecast 2019-2024 ($ billion)
28: Erythropoeitin - Year-over-year growth 2019-2024 (%)
29: Clotting factors - Market size and forecast 2019-2024 ($ billion)
30: Clotting factors - Year-over-year growth 2019-2024 (%)
31: Others - Market size and forecast 2019-2024 ($ billion)
32: Others - Year-over-year growth 2019-2024 (%)
33: Market opportunity by Product
34: Customer landscape
35: Market share by geography 2019-2024 (%)
36: Geographic comparison
37: North America - Market size and forecast 2019-2024 ($ billion)
38: North America - Year-over-year growth 2019-2024 (%)
39: Europe - Market size and forecast 2019-2024 ($ billion)
40: Europe - Year-over-year growth 2019-2024 (%)
41: APAC - Market size and forecast 2019-2024 ($ billion)
42: APAC - Year-over-year growth 2019-2024 (%)
43: South America - Market size and forecast 2019-2024 ($ billion)
44: South America - Year-over-year growth 2019-2024 (%)
45: MEA - Market size and forecast 2019-2024 ($ billion)
46: MEA - Year-over-year growth 2019-2024 (%)
47: Key leading countries
48: Market opportunity by geography ($ billion)
49: Impact of drivers and challenges
50: Vendor landscape
51: Landscape disruption
52: Industry risks
53: Vendors covered
54: Market positioning of vendors
55: AbbVie Inc. - Overview
56: AbbVie Inc. - Business segments
57: AbbVie Inc. - Key offerings
58: AbbVie Inc. - Key customers
59: AbbVie Inc. - Segment focus
60: Amgen Inc. - Overview
61: Amgen Inc. - Business segments
62: Amgen Inc. - Key offerings
63: Amgen Inc. - Key customers
64: Amgen Inc. - Segment focus
65: AstraZeneca Plc - Overview
66: AstraZeneca Plc - Business segments
67: AstraZeneca Plc - Key offerings
68: AstraZeneca Plc - Key customers
69: AstraZeneca Plc - Segment focus
70: Eli Lilly and Co. - Overview
71: Eli Lilly and Co. - Business segments
72: Eli Lilly and Co. - Key offerings
73: Eli Lilly and Co. - Key customers
74: Eli Lilly and Co. - Segment focus
75: F. Hoffmann-La Roche Ltd. - Overview
76: F. Hoffmann-La Roche Ltd. - Business segments
77: F. Hoffmann-La Roche Ltd. - Key offerings
78: F. Hoffmann-La Roche Ltd. - Key customers
79: F. Hoffmann-La Roche Ltd. - Segment focus
80: Johnson & Johnson - Overview
81: Johnson & Johnson - Business segments
82: Johnson & Johnson - Key offerings
83: Johnson & Johnson - Key customers
84: Johnson & Johnson - Segment focus
85: Merck & Co. Inc. - Overview
86: Merck & Co. Inc. - Business segments
87: Merck & Co. Inc. - Key offerings
88: Merck & Co. Inc. - Key customers
89: Merck & Co. Inc. - Segment focus
90: Novo Nordisk AS - Overview
91: Novo Nordisk AS - Business segments
92: Novo Nordisk AS - Key offerings
93: Novo Nordisk AS - Key customers
94: Novo Nordisk AS - Segment focus
95: Pfizer Inc. - Overview
96: Pfizer Inc. - Business segments
97: Pfizer Inc. - Key offerings
98: Pfizer Inc. - Key customers
99: Pfizer Inc. - Segment focus
100: Sanofi - Overview
101: Sanofi - Business segments
102: Sanofi - Key offerings
103: Sanofi - Key customers
104: Sanofi - Segment focus
105: Currency conversion rates for US$
106: Research Methodology
107: Validation techniques employed for market sizing
108: Information sources
109: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global protein therapeutics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novo Nordisk AS, Pfizer Inc., and Sanofi.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the development of novel therapies using innovative technologies."

According to the report, one of the major drivers for this market is the increased demand for mAbs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi